Partial shutdown sees 41% of FDA staff furloughed

FDA has furloughed almost half its staff after the U.S. government partially shut down early Dec. 22, potentially slowing approvals and stalling advisory committee meetings.

Commissioner Scott Gottlieb confirmed in a tweet Friday that FDA cannot accept NDAs or other new regulatory submissions during the shutdown. The agency will not

Read the full 496 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE